Dashboard
Manage Tickers

TXMDTherapeuticsMD, Inc.

Nasdaq therapeuticsmd.com


$ 2.03 $ 0.05 (2.53 %)    

Friday, 14-Jun-2024 15:57:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 2.03
$ 2.03
$ 0.00 x 0
$ 2.03 x 100
$ 2.03 - $ 2.03
$ 1.84 - $ 4.35
10,661
na
23.41M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 04-07-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 07-30-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

therapeuticsmd-q1-eps-007-up-from-024-yoy
TherapeuticsMD Q1 EPS $(0.07) Up From $(0....
05/10/2024 20:07:02

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.07) per share. This is a 70.83 percent increase over losses of $(...

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
03/04/2024 14:44:45

overview-of-value-stocks-in-the-healthcare-sector
Overview Of Value Stocks In The Healthcare...
02/12/2024 14:43:58

a-look-into-healthcare-sector-value-stocks
A Look Into Healthcare Sector Value Stocks
12/25/2023 14:43:43

overview-of-value-stocks-in-the-healthcare-sector
Overview Of Value Stocks In The Healthcare...
11/27/2023 14:43:28

therapeuticsmd-q3-eps-013-misses-005-estimate
TherapeuticsMD Q3 EPS $(0.13) Misses $(0.0...
11/14/2023 21:57:24

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0....

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

  During the session on Thursday, 461 stocks hit new 52-week lows.

cantor-fitzgerald-reiterates-neutral-on-therapeuticsmd-maintains-5-price-target
Cantor Fitzgerald Reiterates Neutral on Th...
08/17/2023 15:48:00

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and maintains $5 price target.

therapeuticsmd-q2-eps-024-misses-007-estimate-sales-from-cont-ops-40000k-miss-50000k-estimate
TherapeuticsMD Q2 EPS $(0.24) Misses $(0.0...
08/14/2023 10:58:47

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0....

Core News & Articles
Overview Of Value Stocks In The Healthcare...
06/05/2023 14:43:31

cigna-is-out-with-a-new-coverage-policy-stating-that-therapeuticsmd-imvexxy-is-now-covered-effective-1124-but-just-disclosed
Cigna Is Out With A New Coverage Policy St...
01/27/2023 16:27:37

https://static.cigna.com/assets/chcp/pdf/coveragePolicies/pharmacy/ip_0216_coveragepositioncriteria_vaginal_estrogen_products.pdf

therapeuticsmd-says-terminated-certain-amended-restated-employment-agreement-between-co-michael-donegan
TherapeuticsMD Says Terminated Certain Ame...
01/18/2023 22:03:37

cantor-fitzgerald-reinstates-neutral-on-therapeuticsmd-announces-5-price-target
Cantor Fitzgerald Reinstates Neutral on Th...
01/11/2023 12:45:33

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
01/02/2023 21:30:42

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
12/05/2022 21:32:37

therapeuticsmd-q3-sales-2092m-down-from-2541m-yoy
TherapeuticsMD Q3 Sales $20.92M Down From ...
11/14/2022 22:03:16

TherapeuticsMD (NASDAQ:TXMD) reported $20.92 million in sales this quarter. This is a 17.67 percent decrease over sales of $25....

therapeuticsmd-announces-7m-private-placement
TherapeuticsMD Announces $7M Private Place...
10/03/2022 10:51:35

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
09/27/2022 21:44:05

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The comp...

therapeuticsmd-appoints-dr-brian-bernick-and-mr-mark-glickman-as-interim-co-chief-executive-officers
TherapeuticsMD Appoints Dr. Brian Bernick ...
09/12/2022 10:50:49

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

looking-into-therapeuticsmds-return-on-capital-employed
Looking Into TherapeuticsMD's Return On Ca...
09/09/2022 14:19:01

According to Benzinga Pro, during Q2, TherapeuticsMD (NASDAQ:TXMD) earned $112.28 million, a 329.05% increase from the precedin...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)